Many European countries have suspended the use of AstraZeneca’s COVID-19 vaccine following reports of blood clots. However, Germany, France and several other EU countries on March 18th decided to continue using the AstraZeneca vaccine after the European Medicines Agency (EMA) shored up confidence in the shot.
Following an investigation into 30 cases of unusual blood disorders, the EMA concluded that the vaccine’s benefits in protecting people from coronavirus outweighs the possible risks, though a link between blood clots and the shot could not be definitively ruled out.
Germany resumed administering the AstraZeneca vaccine from March 19th. German Health Minister Jens Spahn said suspending the vaccine out of caution had been the right call. French Prime Minister Jean Castex received the shot himself on March 19th. It is up to individual EU states to decide whether and when to re-start vaccinations using the AstraZeneca vaccine.